Today: 3 July 2026
Browse Category

NASDAQ:DOCU 4 December 2025 - 5 June 2026

DocuSign Shares Fall After Earnings Beat, AI Prospects in Focus

DocuSign Shares Fall After Earnings Beat, AI Prospects in Focus

Docusign Inc. shares dropped in late trading Thursday after the company topped Wall Street estimates for first-quarter profit and revenue but stuck close to consensus on guidance, keeping investors cautious about its AI growth story. The stock slipped 2.8% to finish at $50.94, then slid another 4.2% to $48.78 as of 5:45 p.m. EDT. Docusign’s latest step is drawing attention as investors want to see if its e-signature service can grow into a full contract automation platform. In the run-up to earnings, the market was watching to see if the company’s focus on artificial intelligence would “accelerate growth” as the core e-signature market matures and digital signatures are now just standard.
5 June 2026
···
Anthropic Launches Claude for Small Business to Take On Payroll, Invoices and Marketing

Anthropic Launches Claude for Small Business to Take On Payroll, Invoices and Marketing

San Francisco, May 13, 2026, 11:03 AM PDT On Wednesday, Anthropic rolled out Claude for Small Business—a product that integrates its Claude AI assistant with platforms like Intuit QuickBooks, PayPal, HubSpot, Canva, Docusign, Google Workspace and Microsoft 365. The company says Claude takes on payroll planning, monthly book closures, invoice follow-ups and sales campaign management for smaller firms.
13 May 2026
······
DocuSign Adds Redis CEO to Board as AI Contract Push Faces Bigger Test

DocuSign Adds Redis CEO to Board as AI Contract Push Faces Bigger Test

Docusign, Inc. has tapped Rowan Trollope—currently CEO at Redis—for a board seat, bringing on a leader with a background in both AI and cybersecurity. The move, aimed at bolstering Docusign's expansion into contract-management software, was disclosed Wednesday. Trollope’s appointment became official May 2, according to a regulatory filing. Docusign is shifting gears, moving away from its image as just an electronic signature provider and aiming to become a wider player in what it calls Intelligent Agreement Management, or IAM. That umbrella covers not only eSignature, but also the Docusign Iris AI engine, the Navigator agreement repository, and the Maestro workflow builder, according to its annual report. The company pitches IAM as a suite for creating, negotiating, signing, and managing contracts even after execution.
7 May 2026
······
DocuSign Stock Rises After Earnings Beat, $2 Billion Buyback Boost and Strong 2027 Revenue Outlook

DocuSign Stock Rises After Earnings Beat, $2 Billion Buyback Boost and Strong 2027 Revenue Outlook

DocuSign topped Wall Street’s expectations for its fiscal fourth quarter, tacked $2 billion onto its share buyback authorization, and projected revenue for the new fiscal year that outpaces consensus. Shares climbed roughly 1.5% in after-hours trading. The timing of the update isn’t ideal for the software maker. DocuSign shares had already dropped 31% this year, dragged down by a wider selloff in software names and concerns about AI’s potential to disrupt the industry. Investors have been waiting to see if DocuSign can leverage its sizable electronic-signature user base and expand into IAM-driven agreements software.
18 March 2026
··
Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

Asian shares tracked higher Wednesday, with Japan’s Nikkei surging 2.2% to 58,583.12. U.S. stocks recovered from a tech slump, the S&P 500 adding 0.8% to 6,890.07, while the Dow tacked on 370 points to 49,174.50. Dow futures showed little movement as investors looked ahead to Nvidia’s results due after the bell. This week’s moves have circled around a single question: are AI innovations going to juice profits, or wipe them out? Traders have been quick to dump shares exposed to automation — what’s being dubbed on some trading desks as the “AI scare trade,” triggered by anxiety that AI could cut into swathes of software and services revenue. Then, as headlines cooled, buyers snapped stocks right back. “It’s a relief rally after broad-based, indiscriminate selling,” said Ritesh Ganeriwal, head of investment at Syfe in Singapore.
25 February 2026
··········
DocuSign (DOCU) Stock: Earnings Beat, AI Push and Analyst Forecasts as of December 10, 2025

DocuSign (DOCU) Stock: Earnings Beat, AI Push and Analyst Forecasts as of December 10, 2025

Published: December 10, 2025 DocuSign, Inc. is back in the spotlight after a strong fiscal Q3 2026 earnings beat, a fresh AI investment in Europe, and a sharp share-price swing driven by “conservative” guidance. As of the last close on December 9, 2025, DocuSign stock finished at $69.39, up just over 5% on the day but still down roughly 23% year to date and about 35% below its high from last December. StockAnalysis+2MarketScreener+2
10 December 2025
···
DocuSign (DOCU) Stock After Q3 2026 Earnings: AI Pivot Deepens as Shares Slide – December 5, 2025

DocuSign (DOCU) Stock After Q3 2026 Earnings: AI Pivot Deepens as Shares Slide – December 5, 2025

Updated: December 5, 2025 – suitable for Google News & Discover DocuSign, Inc. is back in the spotlight after reporting fiscal Q3 2026 results on December 4 that beat Wall Street expectations on both revenue and earnings, while reiterating its strategic shift from pure e‑signature to an AI‑driven Intelligent Agreement Management platform. Yet the stock is trading well below its 2025 highs as investors weigh modest single‑digit growth against strong profitability and an ambitious AI roadmap. DocuSign Investors+224/7 Wall St.+2
5 December 2025
···
US Stock Market Today, December 4, 2025: Wall Street Ends Mixed Near Record Highs as Fed Rate‑Cut Bets Build

US Stock Market Today, December 4, 2025: Wall Street Ends Mixed Near Record Highs as Fed Rate‑Cut Bets Build

The US stock market closed Thursday in quietly positive fashion, with major indexes hovering near record highs while investors leaned into hopes for a Federal Reserve rate cut next week and digested a fresh batch of labor data and earnings. At the closing bell on December 4, 2025:
4 December 2025
···········
DocuSign Q3 2026 Earnings Beat Forecasts as AI Strategy Scales, But DOCU Stock Slips on Soft Q4 Outlook

DocuSign Q3 2026 Earnings Beat Forecasts as AI Strategy Scales, But DOCU Stock Slips on Soft Q4 Outlook

Updated: December 4, 2025 DocuSign, Inc. reported fiscal third‑quarter 2026 results for the period ended October 31, 2025, posting stronger‑than‑expected revenue and earnings and nudging its full‑year guidance higher. However, the initial market reaction was muted to negative: the stock traded 2–4% lower at points in extended and afternoon trading, as investors zeroed in on cautious fourth‑quarter guidance and questions about the durability of growth. Red94+3PR Newswire+3Investing.com+3
4 December 2025
··

Stock Market Today

  • Raffles Medical Group (SGX:BSL) jumps after AI brain imaging partnership, valuation gap in focus
    July 3, 2026, 12:51 PM EDT. Raffles Medical Group (SGX:BSL) moved after a new partnership with Neurophet to provide AI software for brain MRI scans tied to neurodegenerative diseases. Shares traded at SGD0.93. The one-year shareholder return sits at -5.04%; year-to-date, the stock is down 8.82%. The P/E ratio is 24.3 times, which is below the peer group average of 29.4 but higher than the Asian healthcare industry's 19.9 and just above a calculated fair P/E of 23.8. A DCF model puts value 38.9% higher at SGD1.52, pointing to possible undervaluation. The market is weighing those potential gains against earnings risks and regulatory uncertainty in Singapore and Greater China.
Go toTop